Oculis Ownership | Who Owns Oculis?
Oculis Ownership Summary
Oculis is owned by 8.50% institutional investors, 3.61% insiders, and 87.90% retail investors. Eqt fund management s.a r.l. is the largest institutional shareholder, holding 10.54% of OCS shares.
OCS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Oculis | 8.50% | 3.61% | 87.90% |
| Sector | Healthcare Stocks | 35.34% | 11.88% | 52.77% |
| Industry | Biotech Stocks | 35.37% | 11.83% | 52.80% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Eqt fund management s.a r.l. | 5.90M | 10.54% | $156.89M |
| Abrdn | 1.75M | 3.12% | $46.45M |
| Pivotal bioventure partners investment advisor | 1.68M | 3.00% | $44.68M |
| Wellington management group llp | 1.35M | 2.40% | $35.78M |
| Millennium management | 913.03K | 1.63% | $24.28M |
| Adage capital partners gp | 833.21K | 1.49% | $22.16M |
| Sr one capital management, lp | 641.02K | 1.14% | $17.04M |
| Saturn v capital management | 516.76K | 0.92% | $13.74M |
| Perceptive advisors | 493.83K | 0.88% | $13.13M |
| Eventide asset management | 430.00K | 0.77% | $11.43M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pivotal bioventure partners investment advisor | 1.68M | 15.97% | $44.68M |
| Eqt fund management s.a r.l. | 5.90M | 15.37% | $156.89M |
| Nan fung group | 350.75K | 7.69% | $9.33M |
| Saturn v capital management | 516.76K | 2.49% | $13.74M |
| Propel bio management | 122.22K | 2.07% | $3.28M |
| Sr one capital management, lp | 641.02K | 1.86% | $17.04M |
| Acuta capital partners | 98.34K | 1.84% | $2.61M |
| Syquant capital sas | 222.87K | 0.93% | $5.93M |
| Perceptive advisors | 493.83K | 0.26% | $13.13M |
| Eventide asset management | 430.00K | 0.19% | $11.43M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 913.03K | 0.01% | 897.39K |
| Adage capital partners gp | 833.21K | 0.03% | 833.21K |
| Eventide asset management | 430.00K | 0.19% | 430.00K |
| Folketrygdfondet | 319.56K | 0.15% | 136.76K |
| Hrt financial lp | 148.02K | 0.01% | 104.11K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Pivotal bioventure partners investment advisor | 1.68M | 15.97% | -608.38K |
| Nan fung group | 350.75K | 7.69% | -163.96K |
| Neo ivy capital management | - | - | -54.77K |
| Propel bio management | 122.22K | 2.07% | -50.62K |
| Marshall wace, llp | - | - | -45.77K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Adage capital partners gp | 833.21K | 0.03% | 833.21K | $22.16M |
| Eventide asset management | 430.00K | 0.19% | 430.00K | $11.43M |
| Jane street group | 90.16K | 0.00% | 90.16K | $2.40M |
| Goldman sachs group | 67.75K | 0.00% | 67.75K | $1.80M |
| Point72 asset management | 56.13K | 0.00% | 56.13K | $1.49M |
Sold Out
| Holder | Change |
|---|---|
| Sbi securities | -1.00 |
| China universal asset management | -2.00K |
| Gsa capital partners llp | -13.04K |
| Two sigma investments, lp | -24.44K |
| Renaissance | -25.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 15 | -63.41% | 4,756,937 | -73.68% | 8 | 0.72% | 7 | -77.42% | 4 | - |
| Dec 31, 2025 | 41 | 105.00% | 18,075,560 | 65.92% | 34 | 8.02% | 31 | 520.00% | 4 | -42.86% |
| Sep 30, 2025 | 20 | -13.04% | 10,893,907 | 113.37% | 20 | 21.69% | 5 | -61.54% | 7 | 133.33% |
| Jun 30, 2025 | 23 | 15.00% | 5,105,646 | 2.56% | 9 | 9.18% | 13 | -27.78% | 3 | 200.00% |
| Mar 31, 2025 | 20 | 66.67% | 4,978,440 | 42.50% | 10 | 13.80% | 18 | 125.00% | 1 | - |
OCS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools